Our progress against bladder cancer
Researchers in our Clinical Trials and Statistics Unit (CTSU) led a landmark clinical trial which looked at different ways of giving radiotherapy to patients with bladder cancer.
The trial found that giving radiotherapy and chemotherapy at the same time helped stop bladder cancer from coming back, without causing more long term side effects.
This led to changes in clinical guidance, improving the quality of life for patients with bladder cancer.
We are improving how radiotherapy is used to treat bladder cancer.
In a recent study, our researchers showed that a shorter radiotherapy course with fewer but larger doses reduced the risk of bladder cancer coming back after treatment, with no increased risk of side effects, and would mean patients needing 12 fewer trips to hospital.
We are now strongly advocating for clinical guidance to be changed so that more patients can access the shorter radiotherapy course.